Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer

Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer

Yuanyuan Wang,1 Min Fu,2 Jingjing Liu,2 Yining Yang,1 Yibin Yu,1 Jinyu Li,1 Weisan Pan,1 Lei Fan,3 Guiru Li,4 Xuetao Li,2 Xiaobo Wang1,31Department of Pharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning, People’s Republic of China; 2School of Pharmacy, Liaoning University...

Full description

Bibliographic Details
Main Authors: Wang Y, Fu M, Liu J, Yang Y, Yu Y, Li J, Pan W, Fan L, Li G, Li X, Wang X
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:International Journal of Nanomedicine
Subjects:
daunorubicin
dioscin
liposomes
cell penetrating peptides
tumor metastasis
non-small-cell lung cancer
Online Access:https://www.dovepress.com/inhibition-of-tumor-metastasis-by-targeted-daunorubicin-and-dioscin-co-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/inhibition-of-tumor-metastasis-by-targeted-daunorubicin-and-dioscin-co-peer-reviewed-article-IJN

Similar Items